Company Filing History:
Years Active: 2017
Title: Lars Erik Berglund: Innovator in Transgenic Plant Technology
Introduction
Lars Erik Berglund is a notable inventor based in Odder, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic plants. His work focuses on the expression of vitamin B12 binding proteins, which has important implications for health and nutrition.
Latest Patents
Berglund holds a patent for "Transgenic plants expressing cobalamin binding proteins." This invention relates to the use of transgenic plants for the expression of vitamin B12 binding proteins. The plant cells are transformed with nucleotide sequences that are specifically adapted for the expression and secretion of these proteins. The patent also discusses the use of recombinant vitamin B12 binding proteins from plants in analytical tests and the treatment of vitamin B12 deficiency. Additionally, it discloses a method for the purification of these recombinant proteins.
Career Highlights
Berglund is associated with Xeragenx LLC, where he continues to advance his research and innovations. His work has the potential to address nutritional deficiencies and improve health outcomes through biotechnological advancements.
Collaborations
Berglund has collaborated with notable colleagues, including Torben Ellebaek Petersen and Sergey Nikolaevich Fedosov. These partnerships have contributed to the success and impact of his research in the field.
Conclusion
Lars Erik Berglund is a pioneering inventor whose work in transgenic plants is paving the way for innovative solutions to vitamin B12 deficiency. His contributions to biotechnology are significant and hold promise for future advancements in health and nutrition.